The role of molecular imaging in modern drug development

作者: Lídia Cunha , Krisztián Szigeti , Domokos Mathé , Luís F. Metello

DOI: 10.1016/J.DRUDIS.2014.01.003

关键词:

摘要: Drug development represents a highly complex, inefficient and costly process. Over the past decade, widespread use of nuclear imaging, owing to its functional molecular nature, has proven be determinant in improving efficiency selecting candidate drugs that should either abandoned or moved forward into clinical trials. This helps not only with safer effective but also shortening time-to-market. The modern concept future trends concerning imaging will assumedly hybrid multimodality including combinations between high sensitivity (molecular) modalities spatial resolution morphological techniques.

参考文章(81)
Philipp Malle, Manfred Sorschag, Hans-Jürgen Gallowitsch, FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours Wiener Medizinische Wochenschrift. ,vol. 162, pp. 423- 429 ,(2012) , 10.1007/S10354-012-0131-Y
Willi A. Kalender, Paul Deak, Klaus Engelke, Marek Karolczak, X-Ray and X-Ray-CT Small Animal Imaging. pp. 125- 139 ,(2011) , 10.1007/978-3-642-12945-2_10
Anne Leroy-Willig, Danielle Geldwerth-Feniger, Nuclear Magnetic Resonance Imaging and Spectroscopy John Wiley & Sons, Ltd. pp. 1- 56 ,(2007) , 10.1002/9780470029596.CH1
Paul M. Matthews, Eugenii A. Rabiner, Jan Passchier, Roger N. Gunn, Positron emission tomography molecular imaging for drug development. British Journal of Clinical Pharmacology. ,vol. 73, pp. 175- 186 ,(2012) , 10.1111/J.1365-2125.2011.04085.X
Christoph Bremer, Vasilis Ntziachristos, Ralph Weissleder, Optical-based molecular imaging: contrast agents and potential medical applications. European Radiology. ,vol. 13, pp. 231- 243 ,(2003) , 10.1007/S00330-002-1610-0
Bertrand Tavitian, Régine Trbossen, Roberto Pasqualini, Frédéric Doll, In Vivo Radiotracer Imaging John Wiley & Sons, Ltd. pp. 103- 147 ,(2007) , 10.1002/9780470029596.CH4
Bengt Andrée, Ann Hedman, Seth-Olav Thorberg, Dag Nilsson, Christer Halldin, Lars Farde, Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain Psychopharmacology. ,vol. 167, pp. 37- 45 ,(2003) , 10.1007/S00213-002-1355-0
Paolo Preziosi, Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario? Nature Reviews Drug Discovery. ,vol. 3, pp. 521- 526 ,(2004) , 10.1038/NRD1418